Background/Aims: Remission of gastric mucosa-associated lymphoid tissue (MALT) lymphoma is difficult due to pleomorphic and multifocal endoscopic findings. We investigated the relationship between endoscopic appearances and histological findings of patients followed up after curative treatment for the tumor. We reviewed the follow-up endoscopic findings at least 2 months after Helicobacter pylori eradication or chemoradiotherapy. Target biopsy sites were categorized according to their endoscopic appearance.
INTRODUCTION
Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a rare type of B-cell non-Hodgkin's lymphoma derived from marginal zone B-cells. First reported in 1983 by Isaacson and Wright, 1 this lymphoma is of indolent type and believed to be acquired in response to chronic Helicobacter pylori infection. 2, 3 Eradication of H. pylori infection leads to regression of gastric MALT lymphoma in most cases and patients generally show a favorable longterm prognosis. [4] [5] [6] Follow-up endoscopy should be performed regularly for patients with gastric MALT lymphoma after treatment to evaluate the treatment response or confirm complete remission (CR). Currently, biopsy is the gold standard for evaluation of remission in patients with gastric MALT lymphoma and endoscopists should perform a target biopsy for correct histological diagnosis. However, evaluation of remission can be difficult even after biopsy because of pleomorphic and multifocal endoscopic findings. For this reason, guidelines for gastric MALT lymphoma recommend a gastric mapping procedure to assess the treatment response to H. pylori eradication, radiation or chemotherapy, suggesting multiple biopsies should be taken from all visible lesions and even normal mucosa. 7, 8 Studies regarding the type of lesions that should be biopsied during the follow-up endoscopy are lacking. In a study of 47 H. pylori-positive patients with low-grade gastric MALT lymphoma who were treated with triple therapy, Urakami et al. 9 showed the appearance of whitish mucosa after histological regression reflected the degree of gastric gland loss. The authors proposed that whitish mucosa is an endoscopic characteristic and may be an endoscopic marker for regression of low-grade gastric MALT lymphoma. In this study we investigated the relationship between the endoscopic appearances and histological findings in patients followed up after curative treatment for gastric MALT lymphoma. Staging was determined using the Lugano staging system based on detailed physical examination, laboratory tests, chest and abdomen CT, endoscopic ultrasonography and bone marrow examination (if clinically indicated). 10 Initial treatment was performed according to the stage. Patients with stage I (which is confined to gastric mucosa) were given a standard 7-day regimen of lansoprazole, Values are presented as n (%) or mean (range).
MATERIALS AND METHODS

Patients and clinical data
amoxicillin and clarithromycin. In the case of H. pylori-negative localized stage, involved site radiation therapy was added to the eradication therapy if clinically indicated. Patients with advanced stage were treated with a combination of eradication therapy and chemotherapy. All follow-up endoscopies were evaluated; those without biopsies, endoscopies with biopsies in which the target lesion was difficult to clarify and endoscopies within 2 months after treatment were excluded.
Endoscopic classification: initial work-up and follow-up
Endoscopic classifications for gastric MALT lymphoma during initial work-up included exophytic, ulceroinfiltrative and superficial types. In accordance with Yokoi's classification, 11 superficial lesions were divided into the following six types: IIc-like type, submucosal tumor type, multiple erosion type, cobblestone-mucosa type, partial-fold swelling type and discoloration type. If a patient had more than two main lesions, each lesion was recorded and classified separately. There is no universally accepted classification of follow-up endoscopic appearance of gastric MALT lymphoma. Therefore, we defined any mucosal lesions found during the follow-up endoscopy of gastric MALT lymphoma as visually suspected lesions (VSLs). Then, according to their height, we categorized VSLs into three groups: depression (erosion, ulcer), elevation (fold thickening, nodule, mass) and flat (discoloration, erythema, ulcer scar). When the mapping biopsy was performed, the normal mucosae were divided into normal and normal atrophy (Fig. 1) .
Regarding the description of follow-up endoscopic findings, two endoscopists (H.H.L. and I.S.L.) reviewed independently all follow-up endoscopic findings of the study patients and described the biopsy site appearance separately. Any disagreements regarding endoscopic appearances were resolved by discussion.
Evaluation of histological findings
Post-treatment biopsies were evaluated histologically using Grouped'Etude des Lymphomes de l'Adult (GELA) grading system. 12 In this system, four morphological categories are identified: complete histological response (CR), probable minimal residual disease (pMRD), responding residual disease and no change. CR or pMRD are considered negative histological findings. Both endoscopists were blinded to the histological findings of the lesions until they reached an agreement regarding the endoscopic appearances of all lesions.
Statistical analysis
Descriptive statistics were used to characterize the demographic features of the study population. Chi-square test or the Fisher exact test was used when appropriate to compare the percentages of positive histology between the groups. Statistical analysis was performed using the SAS for Windows software (ver. 8.02; SAS Institute, Cary, NC, USA). In all analyses, P-values ＜0.05 were considered to indicate statistical significance. Values are presented as number only, mean (range), or n (%). Nineteen cases (76.0%) were classified as stage I disease according to the Lugano stage, whereas the others showed advanced stages. Radiation therapy was added to the H. pylori-negative treatment regimen of one patient.
Chemotherapy was added to six advanced stage patients and one patient in whom eradication therapy appeared ineffective. After initial treatment, five patients did not show an endoscopic or histological response; four received additional chemotherapy and one underwent radiation therapy.
Features of follow-up endoscopies after treatment for gastric MALT lymphoma are summarized in Table 2 . A total of 76 endoscopies was performed. During the procedures, 238 biopsies were performed for evaluation of the histological response and categorized into depression, elevation, flat and normal groups, as mentioned previously. Among the four groups, the flat was the most common endoscopic appearance (118/238, 49.6%). Mapping biopsies of normal mucosa were performed in selected cases (68/238; 28.6%). Positive histological findings according to endoscopic appearance are shown in Table 3 ; 37.5% (3/8), 25.0% (11/44), 29.7% (35/118) and 1.5% (1/68) positive biopsies were found in the depression, elevation, flat and normal groups, respectively. Positive rates were not significantly different among the three VSLs (depression, elevation and flat). Conversely, positive rates were significantly different between VSLs and the normal group (Fig. 2 ).
Subgroup analyses
The percent of positive biopsies was also analyzed after dividing total follow-up endoscopies according to the time elapsed since the last treatment. Positive rates of follow-up biopsies within 1 year and after 1 year were 24.0% (36/150) and 15.9% (14/88), respectively (Table 4 ).
There were no statistically significant differences among the four groups.
In the subgroup of stage I patients who showed successful eradication after triple therapy, Table 5 shows the percent of positive biopsies for each group. The overall positive rate was 20.0% (32/160), which was similar to the rate of the entire study population (21.0%). Discoloration was the most common endoscopic finding, and the positive rate of biopsies for this lesion was 40.1% (21/52).
DISCUSSION
In this study we investigated the relationship between the endoscopic appearances and histological findings in patients followed up after curative treatment for gastric MALT lymphoma. In this retrospective review of 25 gastric MALT lymphoma patients, we showed VSLs such as depression, elevation and flat had significantly more positive histological findings compared with normal mucosa.
Gastric MALT lymphoma has uncharacteristically few classic B symptoms (fever, night sweats and weight loss). 13 In addition, alarm symptoms such as persistent vomiting, anemia or gastrointestinal bleeding are present in only approximately half of patients with this lymphoma.
14 Therefore, gastric MALT lymphoma is often found by chance following a gastroduodenoscopy performed for medical check-up or vague gastrointestinal symptoms. Similarly, the endoscopic appearances of gastric MALT lymphoma are multifarious and unpredictable, causing misdiagnosis of this disease as gastritis, gastric ulcer, or gastric cancer, and multiple biopsies are necessary for accurate diagnosis. Despite this effort, more than 20% of cases require a repeated endoscopy with biopsy. 15 The optimal interval for follow-up endoscopy and strategy for endoscopic biopsy are unclear. National Comprehensive Cancer Network guidelines recommend that endoscopy with biopsy should be performed to exclude large cell lymphoma at 3 months after initial therapy. However, the target site or number of biopsies is not mentioned. 16 According to the European Gastro-Intestinal Lymphoma Study consensus report, follow-up endoscopy with biopsy mapping, including a minimum of 10 biopsies from visible lesions and macroscopically normal mucosae should be performed and initial sites of lymphoma involvement should be evaluated. 7 European Society for Medical Oncology guidelines also suggest that sequential evaluation of multiple gastric biopsies is essential to exclude the possibility of significant persistent disease and watch for early epithelial changes, which may be related to gastric carcinoma. 17 In the present study, any mucosal lesions observed during the follow-up endoscopy of gastric MALT lymphoma were defined as "VSLs". Our analysis demonstrated that VSLs had significantly higher positive rates of post-treatment biopsies when compared with normal mucosae, whereas there was no significant difference among the three VSL groups. Discoloration, mucosal thickening and ulcer scar represented the majority of VSLs. Rates of positive biopsies for VSLs at more than 1 year after last treatment were decreased compared with those within 1 year, but the difference was not statistically significant.
Urakami et al. 9 reported that whitish mucosa after successful H. pylori eradication is a good indicator of histological regression. In this study, among 42 patients with successful eradication, 31 (74%) showed whitish mucosa, which correlated well with loss of gastric glands. Urakami et al. 9 suggested that the gastric glands are destroyed by the neoplastic infiltration and the lamina propria becomes empty after eradication. These findings are inconsistent with our results; the positive rate of biopsies for discoloration was ∼40% even after successful eradication in stage I gastric MALT lymphoma. One possible explanation is that whitish mucosal change indicates the depletion of gastric glands, although the surrounding discolored mucosae may still contain malignant cells. Therefore, discolored lesions during follow-up endoscopy could have remnant or recurrent lymphoma tissue and should be carefully observed and biopsied.
In conclusion, endoscopic appearances after gastric MALT lymphoma treatment−such as depressive lesion (ulcer and erosion), mucosal thickening, discoloration and ulcer scar−do not appear to be correlated with pathological remission. These lesions should be biopsied during follow-up of treatment for gastric MALT lymphoma.
